| Baseline | After 12 weeks | Change from baseline to post treatment measurements | MD | 95% CI | Effect size (d) |
---|---|---|---|---|---|---|
Nutritional Hematological | ||||||
RBP (mg/dL) | ||||||
 PAG (n 20) | 3.0 [0.7] | 3.0 [0.6] | 0.02 [0.5] | 0.98 | 0.48, 1.46 | 1.60 |
 RAG (n 22) | 3.3 [1.5] | 4.3 [1.3] | 1.0 [0.7] | |||
PA (mg/dL) | ||||||
 PAG (n 32) | 23.4 [3.7] | 22.9 [4.6] | −0.5 [2.6] | 2.84 | 0.93, 4.76 | 0.77 |
 RAG (n 30) | 23.0 [4.9] | 25.4 [6.7] | 2.4 [4.7] | |||
Tf (mg/dL) | ||||||
 PAG (n 20) | 218.9 [76.6] | 208.0 [67.9] | −10.9 [8.8] | 54.1 | 34.53, 71.82 | 2.94 |
 RAG (n 22) | 216.4 [38.1] | 259.6 [45.0] | 43.2 [24.0] | |||
Hb (g/dL) | ||||||
 PAG (n 32) | 14.1 [1.1] | 13.9 [1.2] | −0.2 [0.9] | 0.90 | 0.54, 1.27 | 1.17 |
 RAG (n 30) | 13.9 [1.6] | 14.6 [1.3] | 0.7 [0.6] | |||
Inflammation Biomarkers | ||||||
Hs-CRP (ng/mL) | ||||||
 PAG (n 12) | 735.3 [445.6] | 717.8 [396.6] | −17.4 [71.7] | − 576.58 | − 610.60, −44.23 | 1.57 |
 RAG (n 10) | 1109.3 [437.2] | 515.3 [247.6] | − 594.0 [542.4] | |||
TNF-α (pg/mL) | ||||||
 PAG (n 12) | 2.5 [0.9] | 2.8 [1.0] | 0.4 [0.8] | −2.09 | −2.44, −0.42 | 1.56 |
 RAG (n 10) | 3.3 [1.5] | 1.6 [1.2] | −1.7 [1.8] | |||
IL-6 (pg/mL) | ||||||
 PAG (n 12) | 2.9 [1.0] | 3.6 [1.4] | 0.7 [1.5] | −2.34 | −3.13, −0.87 | 1.55 |
 RAG (n 10) | 3.3 [1.1] | 1.7 [1.0] | −1.7 [1.6] | |||
SAA (μg/mL) | ||||||
 PAG (n 12) | 5.0 [1.7] | 5.5 [2.4] | 0.5 [1.0] | −2.10 | −3.34, −1.02 | 1.75 |
 RAG (n 10) | 4.4 [1.7] | 2.7 [0.8] | −1.6 [1.4] | |||
COHb (%) | ||||||
 PAG (n 32) | 1.4 [1.0] | 1.9 [1.1] | 0.5 [0.9] | −1.13 | −1.51, −0.69 | 1.10 |
 RAG (n 30) | 1.4 [1.2] | 0.8 [0.6] | −0.6 [1.1] |